In a report released today, Daniel Brennan from TD Cowen reiterated a Buy rating on Adaptive Biotechnologies (ADPT – Research Report).

TD Cowen analyst Phil Nadeau maintained a Hold rating on Xoma (XOMA – Research Report) today. The company’s shares opened today at ...

Jeff Solomon, TD Cowen president, joins CNBC's 'Money Movers' to discuss how a Trump administration will impact the markets ...

Chris Krueger, TD Cowen managing director, joins 'Power Lunch' to discuss the markets could respond depending on the election ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.38% of ...

It took four days for major news organizations to call the 2020 presidential election for Joe Biden, and if polls are correct ...

On Tuesday, Micron Technology Inc (MU) stock saw a modest uptick, ending the day at $105.49 which represents a slight increase of $3.76 or 3.70% from the prior close of $101.73. The stock opened at ...

TD Cowen on potential opportunities in Canadian equities. The potential impact of Canadian mortgage resets in 2025. Why demographic uncertainty could be a major challenge for the Canadian economy.

Logistics professionals navigating their path forward face challenging market conditions, an evolving regulatory environment, a rapidly changing technology landscape, and an increasingly competitive ...

Investing.com -- TD Cowen downgraded SolarEdge Technologies (NASDAQ:SEDG) from Buy to Hold in a research note, citing ongoing challenges in European markets that are expected to delay the company ...

TD Cowen downgraded SolarEdge (SEDG) to Hold from Buy with a price target of $16, down from $35. The firm cites deteriorating demand in Europe for the downgrade. This will delay a volume ...